Peptide record

TPDB06586

Antibacterial Anticancer Antifungal Hemolysis Toxicity standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06586
Antibacterial Anticancer Antifungal Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb PD_Hemolysis
standard
No
A 12-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KRIVKLILKWLR
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C76H136N22O13
ANDCEQGHMFPSTY
LK
1566.06
12.43
5
0
7
+5
1.29
0.250
186.67
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
5500
3.51
0
Residue Composition
number
0
A
2
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
2
I
3
L
3
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 2 L: 3 K: 3 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 1
Chemical Descriptors
12 reviewed residue count
C76H136N22O13 sequence-only estimate (linear, free termini)
1566.06 sequence-only estimate (linear, free termini)
12.43 sequence-only estimate (linear, free termini)
+5 sequence-only estimate (linear, free termini)
1.29 sequence-only estimate (linear, free termini)
0.250 sequence-only estimate (linear, free termini)
Evidence Records 21 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4 µM

Target

Escherichia coli KCTC 1682

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against Gram- E. coli KCTC 1682 (MIC 4 uM), P. aeruginosa KCTC 1637 (MIC 8 uM), S. typhimurium KCTC 1926 (MIC 4 uM), Gram+ B. subtil
Evidence 2 Activity

Activity

MIC
Antibacterial
8 µM

Target

Pseudomonas aeruginosa KCTC 1637

Source & Reference

dbAMP DRAMP

Other

active against Gram- E. coli KCTC 1682 (MIC 4 uM), P. aeruginosa KCTC 1637 (MIC 8 uM), S. typhimurium KCTC 1926 (MIC 4 uM), Gram+ B. subtilis KCTC 3068 (MIC 4 uM), S. epidermi
Evidence 3 Activity

Activity

MIC
Antibacterial
4 µM

Target

S. typhimurium KCTC 1926

Source & Reference

dbAMP DRAMP

Other

active against Gram- E. coli KCTC 1682 (MIC 4 uM), P. aeruginosa KCTC 1637 (MIC 8 uM), S. typhimurium KCTC 1926 (MIC 4 uM), Gram+ B. subtilis KCTC 3068 (MIC 4 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aure
Evidence 4 Activity

Activity

MIC
Antibacterial
4 µM

Target

B. subtilis KCTC 3068

Source & Reference

dbAMP DRAMP

Other

MIC 4 uM), P. aeruginosa KCTC 1637 (MIC 8 uM), S. typhimurium KCTC 1926 (MIC 4 uM), Gram+ B. subtilis KCTC 3068 (MIC 4 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aureus KCTC 1621 (MIC 4 uM). Warning: Nonsta
Evidence 5 Activity

Activity

MIC
Antibacterial
1 µM

Target

Staphylococcus epidermidis KCTC 1917

Source & Reference

dbAMP DRAMP

Other

(MIC 8 uM), S. typhimurium KCTC 1926 (MIC 4 uM), Gram+ B. subtilis KCTC 3068 (MIC 4 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aureus KCTC 1621 (MIC 4 uM). Warning: Nonstandard assays. The peptide can also bi
Evidence 6 Activity

Activity

MIC
Antibacterial
4 µM

Target

Staphylococcus aureus KCTC 1621

Source & Reference

dbAMP DRAMP

Other

C 4 uM), Gram+ B. subtilis KCTC 3068 (MIC 4 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aureus KCTC 1621 (MIC 4 uM). Warning: Nonstandard assays. The peptide can also bind to LPS and show an anti-inflammat
Evidence 7 Activity

Activity

MIC
Antifungal
4 µM

Target

Escherichia coli KCTC 1682

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active against Gram- E. coli KCTC 1682 (MIC 4 uM), P. aeruginosa KCTC 1637 (MIC 8 uM), S. typhimurium KCTC 1926 (MIC 4 uM), Gram+ B. subtil
Evidence 8 Activity

Activity

MIC
Antifungal
8 µM

Target

Pseudomonas aeruginosa KCTC 1637

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active against Gram- E. coli KCTC 1682 (MIC 4 uM), P. aeruginosa KCTC 1637 (MIC 8 uM), S. typhimurium KCTC 1926 (MIC 4 uM), Gram+ B. subtilis KCTC 3068 (MIC 4 uM), S. epidermi
Evidence 9 Activity

Activity

MIC
Antifungal
4 µM

Target

S. typhimurium KCTC 1926

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active against Gram- E. coli KCTC 1682 (MIC 4 uM), P. aeruginosa KCTC 1637 (MIC 8 uM), S. typhimurium KCTC 1926 (MIC 4 uM), Gram+ B. subtilis KCTC 3068 (MIC 4 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aure
Evidence 10 Activity

Activity

MIC
Antifungal
4 µM

Target

B. subtilis KCTC 3068

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

MIC 4 uM), P. aeruginosa KCTC 1637 (MIC 8 uM), S. typhimurium KCTC 1926 (MIC 4 uM), Gram+ B. subtilis KCTC 3068 (MIC 4 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aureus KCTC 1621 (MIC 4 uM). Warning: Nonsta
Evidence 11 Activity

Activity

MIC
Antifungal
1 µM

Target

Staphylococcus epidermidis KCTC 1917

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC 8 uM), S. typhimurium KCTC 1926 (MIC 4 uM), Gram+ B. subtilis KCTC 3068 (MIC 4 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aureus KCTC 1621 (MIC 4 uM). Warning: Nonstandard assays. The peptide can also bi
Evidence 12 Activity

Activity

MIC
Antifungal
4 µM

Target

Staphylococcus aureus KCTC 1621

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

C 4 uM), Gram+ B. subtilis KCTC 3068 (MIC 4 uM), S. epidermidis KCTC 1917 (MIC 1 uM), and S. aureus KCTC 1621 (MIC 4 uM). Warning: Nonstandard assays. The peptide can also bind to LPS and show an anti-inflammat
Evidence 13 Activity

Activity

MHC10
Hemolysis
25 µM
[Ref.28525841] MHC10=25 µM against human red blood cells

Target

human red blood cells

Source & Reference

Hemolytik PD_Hemolysis
DRAMP4
Eur J Med Chem. 2017 Aug 18 136:428-441. doi: 10.1016/j.ejmech.2017.05.028.

Other

Source Activity Label Source Definition
Hemolysis
Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 14 Activity

Activity

HC50
Hemolysis
96 µM
[Ref.24105706] HC50=96 µM against human red blood cells

Target

human red blood cells

Source & Reference

Hemolytik PD_Hemolysis
DRAMP4
J Pept Sci. 2013 Nov 19(11):700-7. doi: 10.1002/psc.2552.
Evidence 15 Activity

Activity

50% Hemolysis
Toxicity
96 µM
Hemolytic Cytotoxic
50% Hemolysis | 96 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity. | J Pept Sci | 2013
Evidence 16 Activity

Activity

10% Hemolysis
Toxicity
25 µM
Hemolytic Cytotoxic
10% Hemolysis | 25 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity. | Eur J Med Chem | 2017
Evidence 17 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Mouse fibroblasts NIH 3T3

Target

Mouse fibroblasts NIH 3T3

Source & Reference

NA
DBAASP
LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity. | Eur J Med Chem | 2017
Evidence 18 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.28525841] MHC10=25 µM against human red blood cells | Cytotoxicity: [Ref.28525841] The cell viability of mouse macrophage RAW264.7 cells is 100%, 116.6%, 112.1%, 115.1%, 112.8%, 106.8% and 108.3% at peptide concentrations of 0, 4, 8, 16, 32, 64, 128 and 256 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Eur J Med Chem. 2017 Aug 18 136:428-441. doi: 10.1016/j.ejmech.2017.05.028.
Evidence 19 Activity

Activity

HC50
Toxicity
96 µM
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.24105706] HC50=96 µM against human red blood cells | Cytotoxicity: [Ref.24105706] The cell viability of RAW264.7 macrophage cells is 96.6%, 100.1%, 96.6%, 96.8%, 81.2%, 3.1%, 0% and 0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 µM.

Target

erythrocytes

Source & Reference

NA
DRAMP
J Pept Sci. 2013 Nov 19(11):700-7. doi: 10.1002/psc.2552.
Evidence 20 Hemolysis

Activity

25 µM
MHC10
[Ref.28525841] MHC10=25 µM against human red blood cells
Hemolysis

Target

human red blood cells

Source & Reference

PD_Hemolysis
Eur J Med Chem. 2017 Aug 18 136:428-441. doi: 10.1016/j.ejmech.2017.05.028.
DRAMP4
PD_Hemolysis
Evidence 21 Hemolysis

Activity

96 µM
HC50
[Ref.24105706] HC50=96 µM against human red blood cells
Hemolysis

Target

human red blood cells

Source & Reference

PD_Hemolysis
J Pept Sci. 2013 Nov 19(11):700-7. doi: 10.1002/psc.2552.
DRAMP4
PD_Hemolysis